# Globus Medical Inc: filings

GMED · NYSE · CIK 1237831 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/gmed.md) · [Financials](/companies/gmed/financials.md) · [Filings](/companies/gmed/filings.md) · [Insiders](/companies/gmed/insiders.md)

## Reports and events: 211 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 332, 8-K 129, SC 13G/A 51, 10-Q 43, 144 40, 3 24, DEFA14A 15, 10-K 14, DEF 14A 14, SD 13, CORRESP 12, SC 13G 9, UPLOAD 9, 425 7, 4/A 5, S-1/A 5, S-8 4, SCHEDULE 13G/A 4, 10-K/A 3, 5 2, EFFECT 2, FWP 2, NT 10-K 2, 10-Q/A 1, 3/A 1, 424B3 1, 424B4 1, 8-A12B 1, 8-K/A 1, ARS 1, CERTNYS 1, S-1 1, S-4 1, S-4/A 1, SCHEDULE 13G 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-08-06 | 17:06 ET | [10-Q](/filings/0001628280-26-054450.md) | Quarterly report, period 2026-06-30 | 0001628280-26-054450 |
| 2026-08-06 | 16:19 ET | [8-K](/filings/0001628280-26-054353.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-26-054353 |
| 2026-06-04 | 16:11 ET | [8-K](/filings/0001628280-26-040784.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001628280-26-040784 |
| 2026-05-07 | 17:03 ET | [10-Q](/filings/0001628280-26-032290.md) | Quarterly report, period 2026-03-31 | 0001628280-26-032290 |
| 2026-05-07 | 16:20 ET | [8-K](/filings/0001628280-26-032164.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-26-032164 |
| 2026-04-24 | 16:04 ET | [DEF 14A](/filings/0001628280-26-027196.md) | Proxy statement, period 2026-06-03 | 0001628280-26-027196 |
| 2026-03-23 | 17:26 ET | [8-K](/filings/0001628280-26-020612.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-26-020612 |
| 2026-02-24 | 17:08 ET | [10-K](/filings/0001628280-26-011209.md) | Annual report, period 2025-12-31 | 0001628280-26-011209 |
| 2026-02-24 | 16:23 ET | [8-K](/filings/0001628280-26-011124.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-26-011124 |
| 2026-01-07 | 16:32 ET | [8-K](/filings/0001628280-26-001189.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-26-001189 |
| 2025-11-06 | 17:10 ET | [10-Q](/filings/0001237831-25-000031.md) | Quarterly report, period 2025-09-30 | 0001237831-25-000031 |
| 2025-11-06 | 16:25 ET | [8-K](/filings/0001237831-25-000029.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001237831-25-000029 |
| 2025-08-07 | 17:05 ET | [10-Q](/filings/0001562762-25-000200.md) | Quarterly report, period 2025-06-30 | 0001562762-25-000200 |
| 2025-08-07 | 16:23 ET | [8-K](/filings/0001562762-25-000198.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001562762-25-000198 |
| 2025-07-21 | 08:05 ET | [8-K](/filings/0001562762-25-000166.md) | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001562762-25-000166 |
| 2025-06-05 | 16:45 ET | [8-K](/filings/0001562762-25-000158.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001562762-25-000158 |
| 2025-05-15 | 16:41 ET | [8-K](/filings/0001562762-25-000131.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001562762-25-000131 |
| 2025-05-08 | 17:19 ET | [10-Q](/filings/0001562762-25-000118.md) | Quarterly report, period 2025-03-31 | 0001562762-25-000118 |
| 2025-05-08 | 16:16 ET | [8-K](/filings/0001562762-25-000114.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001562762-25-000114 |
| 2025-04-25 | 16:20 ET | [DEF 14A](/filings/0001562762-25-000092.md) | Proxy statement, period 2025-06-04 | 0001562762-25-000092 |
| 2025-04-03 | 09:00 ET | [8-K](/filings/0001193125-25-071923.md) | 2.01 Completion of an acquisition or disposition; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-071923 |
| 2025-02-20 | 17:05 ET | [10-K](/filings/0001562762-25-000026.md) | Annual report, period 2024-12-31 | 0001562762-25-000026 |
| 2025-02-20 | 16:20 ET | [8-K](/filings/0001562762-25-000024.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001562762-25-000024 |
| 2025-02-06 | 16:54 ET | [8-K](/filings/0001193125-25-021848.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-021848 |
| 2025-01-08 | 16:45 ET | [8-K](/filings/0001562762-25-000006.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001562762-25-000006 |
| 2024-11-05 | 17:05 ET | [10-Q](/filings/0001562762-24-000254.md) | Quarterly report, period 2024-09-30 | 0001562762-24-000254 |
| 2024-11-05 | 16:20 ET | [8-K](/filings/0001562762-24-000250.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001562762-24-000250 |
| 2024-08-13 | 17:10 ET | [8-K](/filings/0001562762-24-000209.md) | 8.01 Other events | 0001562762-24-000209 |
| 2024-08-06 | 17:06 ET | [10-Q](/filings/0001562762-24-000199.md) | Quarterly report, period 2024-06-30 | 0001562762-24-000199 |
| 2024-08-06 | 16:20 ET | [8-K](/filings/0001562762-24-000195.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001562762-24-000195 |
| 2024-06-06 | 16:15 ET | [8-K](/filings/0001562762-24-000163.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001562762-24-000163 |
| 2024-05-07 | 17:05 ET | [10-Q](/filings/0001562762-24-000126.md) | Quarterly report, period 2024-03-31 | 0001562762-24-000126 |
| 2024-05-07 | 16:21 ET | [8-K](/filings/0001562762-24-000124.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001562762-24-000124 |
| 2024-04-26 | 16:21 ET | [DEF 14A](/filings/0001562762-24-000102.md) | Proxy statement, period 2023-12-31 | 0001562762-24-000102 |
| 2024-02-21 | 18:32 ET | [10-K](/filings/0001562762-24-000032.md) | Annual report, period 2023-12-31 | 0001562762-24-000032 |
| 2024-02-20 | 16:35 ET | [8-K](/filings/0001562762-24-000030.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001562762-24-000030 |
| 2024-02-05 | 16:45 ET | [8-K](/filings/0001562762-24-000019.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001562762-24-000019 |
| 2024-01-10 | 16:35 ET | [8-K](/filings/0001562762-24-000006.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001562762-24-000006 |
| 2023-11-15 | 17:30 ET | [8-K/A](/filings/0001193125-23-278012.md) | 9.01 Financial statements and exhibits | 0001193125-23-278012 |
| 2023-11-07 | 17:30 ET | [10-Q](/filings/0001562762-23-000407.md) | Quarterly report, period 2023-09-30 | 0001562762-23-000407 |
| 2023-11-07 | 16:19 ET | [8-K](/filings/0001562762-23-000405.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001562762-23-000405 |
| 2023-10-02 | 16:25 ET | [8-K](/filings/0001562762-23-000357.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001562762-23-000357 |
| 2023-09-01 | 11:06 ET | [8-K](/filings/0001193125-23-227191.md) | 1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-23-227191 |
| 2023-08-03 | 17:15 ET | [10-Q](/filings/0001562762-23-000307.md) | Quarterly report, period 2023-06-30 | 0001562762-23-000307 |
| 2023-08-03 | 16:20 ET | [8-K](/filings/0001562762-23-000305.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001562762-23-000305 |
| 2023-06-08 | 16:15 ET | [8-K](/filings/0001562762-23-000269.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001562762-23-000269 |
| 2023-05-04 | 17:15 ET | [10-Q](/filings/0001562762-23-000210.md) | Quarterly report, period 2023-03-31 | 0001562762-23-000210 |
| 2023-05-04 | 16:21 ET | [8-K](/filings/0001562762-23-000208.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001562762-23-000208 |
| 2023-05-03 | 17:21 ET | [8-K](/filings/0001193125-23-134571.md) | 8.01 Other events | 0001193125-23-134571 |
| 2023-04-28 | 16:26 ET | [DEF 14A](/filings/0001562762-23-000185.md) | Proxy statement | 0001562762-23-000185 |

Page 1 of 5. [Older](/companies/gmed/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 30, 2026, 11:47 ET. No prices; not investment advice.